Tafnat 25mg Tablets (Tenofovir Alafenamide 25mg): Advanced Antiviral Therapy for Chronic Hepatitis B
As the demand for high-quality antiviral medicines continues to grow worldwide, Tafnat 25mg Tablets (Tenofovir Alafenamide 25mg) has become a preferred treatment option for Chronic Hepatitis B Virus (HBV) infection. Manufactured and exported by Cordium Pharmaceuticals Pvt. Ltd., Tafnat offers superior efficacy with an improved renal and bone safety profile compared to older tenofovir formulations.
Cordium Pharmaceuticals is a trusted pharmaceutical exporter supplying premium-quality medicines to:
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇵🇭 Philippines
🇻🇳 Vietnam
🇦🇪 UAE
🇸🇦 Saudi Arabia
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
🇺🇸 USA
🇬🇧 UK
🇿🇦 South Africa
What is Tafnat 25mg?
Tafnat 25mg Tablets contains Tenofovir Alafenamide (TAF) 25mg, a modern nucleotide reverse transcriptase inhibitor (NRTI) used primarily in the treatment of chronic Hepatitis B infection. It is a prodrug of tenofovir that delivers higher intracellular drug concentrations while reducing systemic exposure, contributing to improved kidney and bone safety.
Mechanism of Action of Tenofovir Alafenamide (TAF)
Tenofovir Alafenamide is converted inside liver cells into the active metabolite tenofovir diphosphate. This active form:
Inhibits the HBV reverse transcriptase (viral polymerase).
Blocks viral DNA synthesis.
Causes premature termination of viral DNA chain elongation.
Prevents Hepatitis B virus replication.
Helps reduce viral load and liver inflammation.
Why TAF is Preferred Over TDF
Compared with Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide:
Delivers higher drug levels inside infected liver cells.
Uses a lower dose (25 mg).
Reduces kidney toxicity.
Improves bone mineral safety.
Maintains strong antiviral efficacy.
Uses of Tafnat 25mg Tablets
Tafnat 25mg is indicated for:
Chronic Hepatitis B (HBV) infection in adults with compensated liver disease.
Long-term suppression of Hepatitis B viral replication.
Reduction of liver inflammation.
Prevention of progression to liver cirrhosis.
Reduction in the risk of liver failure and hepatocellular carcinoma in appropriately selected patients.
Note: Use should always be under the supervision of a qualified healthcare professional.
Key Benefits of Tafnat 25mg
✅ Potent antiviral activity
✅ Lower kidney toxicity
✅ Better bone safety profile
✅ Once-daily oral dosing
✅ Excellent patient compliance
✅ Effective long-term viral suppression
✅ Suitable for chronic HBV management
Product Information
Parameter Details
Brand Name Tafnat 25mg Tablets
Generic Name Tenofovir Alafenamide
Strength 25 mg
Dosage Form Film-Coated Tablets
Therapeutic Category Antiviral
Indication Chronic Hepatitis B
Administration Oral
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
Cordium Pharmaceuticals Pvt. Ltd. is committed to delivering internationally compliant pharmaceutical products through:
WHO-GMP quality standards
Stringent quality assurance
Competitive export pricing
Reliable global logistics
Private labeling and contract manufacturing (where available)
Timely international delivery
Regulatory documentation support for export markets
Global Export Markets
Cordium Pharmaceuticals exports Tafnat 25mg Tablets to healthcare distributors, hospitals, pharmacies, and government procurement agencies across:
Kenya
Nigeria
Ghana
Philippines
Vietnam
UAE
Saudi Arabia
Uzbekistan
Kazakhstan
USA
UK
South Africa
